Suven Pharma reported a 78% YoY rise in Q3FY25 net profit to Rs 83.3 crore, with revenue growing 40% to Rs 307.2 crore, ...

On a quarterly basis the net profit grew 65% from INR 11.2 Cr in Q2 FY25. For the quarter under review, revenue crossed INR 700 Cr, up by 49% YoY from INR 469 Cr in Q3 FY24. Sequentially, it ...

year-on-year (YoY). At the operational level, Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) during the quarter ended December 2024 grew by 17.2% to ₹1,681 crore from ...

NATCO Pharma stock has declined 34% over six days due to disappointing Q3 FY25 results, including a 37.4% revenue drop and a ...

marking a nearly 21 percent year-on-year (YoY) growth, driven by stable customer retention and rising demand for its AI-powered solutions. During the year, the company's operating profit touched ...

Out of total 15 models, 10 from the list were from Maruti alone, while Hyundai also registered record sales for the Creta ...

a 97% year-on-year (YoY) from EGP 2.260 billion, according to the financial results. The revenues increased to EGP 2.285 billion in the nine-month period ended September 30th, 2024, from EGP 1.410 ...

Qalaa Holdings achieved a 75% year-on-year (YoY) hike in revenues in the third quarter (Q3) of 2024, recording EGP 37.6 billion, according to the financial results. This growth was mainly driven by ...

today announced a remarkable 236% year-over-year (YoY) surge in revenue for FY 2024, solidifying its position as a driving force in the global digital asset ecosystem. The company’s mining ...

announced a remarkable 150% year-on-year (YoY) surge in trading volume, fueled by the explosive growth of AI and meme tokens in 2024. This milestone reflects a broader global trend, as the overall ...

If correct, this will mark an increase of 109% year-over-year and 65% quarter-over-quarter for Coinbase, Coin Metrics said in a Feb. 11 report. Coinbase’s Q4 2024 earnings report is scheduled ...